Section of Vascular Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI.
Section of Vascular Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI; Jobst Vascular Institute of ProMedica, Toledo, OH.
J Vasc Surg Venous Lymphat Disord. 2024 Jul;12(4):101723. doi: 10.1016/j.jvsv.2023.101723. Epub 2023 Dec 20.
The 2010 Pacific Vascular Symposium 6 (PVS6) brought venous disease content experts together with a goal of addressing critical issues collated together in the next decade with concrete plans to achieve these goals. This mapping review aims to provide a broader representation of how progress in critical issues of chronic venous disease has been made by extrapolating scientific publications related to the PVS6 initiatives.
We performed a mapping review identifying original or systematic review/meta-analysis articles related to PVS 6 initiatives (aims) that addressed one of the following key objectives: scales to measure chronic venous disease, effectiveness of interventional deep venous thrombus removal, development of a deep venous valve, and biomarkers related to venous disease. Searches were undertaken in PubMed, Ovid Medline, Cochrane Library, Embase (Elsevier), CINAHL (EBSCO), and Scopus. We extracted descriptive information about the studies and predefined variables for each specific aim, showing what and where research exists on the aims included.
A total of 2138 articles were screened from 3379 retrieved articles from six electronic databases. We mapped 186 included articles, finding that the total number of publications significantly increased after the 2010 PVS6 meeting. Aim results were visually summarized. The largest body of data addressed catheter-based thrombus removal strategies for acute iliofemoral deep venous thrombosis. Primary research on artificial venous valves and venous biomarkers remained limited. No new post-thrombotic syndrome (PTS) score has been developed.
This mapping review identified and characterized the available evidence and gaps in our knowledge of chronic venous disease that exist visually, which may guide where more significant investments for the future should be targeted.
2010 年太平洋血管学会第 6 次会议(PVS6)汇集了静脉疾病领域的专家,旨在解决未来十年内亟待解决的关键问题,并制定具体计划来实现这些目标。本综述旨在更广泛地展示通过推断与 PVS6 倡议相关的科学出版物,在慢性静脉疾病关键问题上取得的进展。
我们进行了映射回顾,确定了与 PVS6 倡议(目标)相关的原始或系统评价/荟萃分析文章,这些文章涉及以下关键目标之一:评估慢性静脉疾病的量表、介入性深静脉血栓清除的效果、深静脉瓣膜的开发以及与静脉疾病相关的生物标志物。在 PubMed、Ovid Medline、Cochrane 图书馆、Embase(Elsevier)、CINAHL(EBSCO)和 Scopus 中进行了检索。我们提取了关于研究的描述性信息和每个特定目标的预定义变量,展示了针对包含目标的研究现状和分布情况。
从 6 个电子数据库中检索到的 3379 篇文章中筛选出 2138 篇。我们映射了 186 篇纳入的文章,发现 2010 年 PVS6 会议后发表的文章数量显著增加。目标结果进行了直观总结。最大的研究群体是针对急性髂股深静脉血栓形成的基于导管的血栓清除策略。人工静脉瓣膜和静脉生物标志物的原始研究仍然有限。尚未开发新的血栓后综合征(PTS)评分。
本映射回顾确定并描述了慢性静脉疾病现有知识的现有证据和差距,这可以直观地指导未来应将更多的重大投资投向何处。